Jafron Biomedical Co

Jafron Biomedical Co Intangible Assets

The Intangible Assets of Jafron Biomedical Co (300529.SZ) as of Oct 16, 2026 is 97.75 M CNY. In the previous year, Intangible Assets was 100.37 M CNY — a change of -2.60% (lower).

Intangible Assets

97.75 MCNY

YoY

-2.60%

Last updated:

Intangible Assets of Jafron Biomedical Co is 2024 97.75 M CNY. Intangible Assets of Jafron Biomedical Co was 2023 100.37 M CNY. It decreases by -2.60% lower compared to the previous year.

The Jafron Biomedical Co Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
30.90 M CNY
Jan 1, 2018
46.60 M CNY
Jan 1, 2019
48.10 M CNY
Jan 1, 2020
89.90 M CNY
Jan 1, 2021
101.31 M CNY
Jan 1, 2022
100.43 M CNY
Jan 1, 2023
100.37 M CNY
Jan 1, 2024
97.75 M CNY
The Jafron Biomedical Co Intangible Assets history
YEARIntangible AssetsYoY
97.75 MCNY-2.60%
100.37 MCNY-0.06%
100.43 MCNY-0.87%
101.31 MCNY+12.69%
89.90 MCNY+86.90%
48.10 MCNY+3.22%
46.60 MCNY+50.81%
30.90 MCNY+80.70%
17.10 MCNY-2.29%
17.50 MCNY+4.79%
16.70 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jafron Biomedical Co Stock analysis

What does Jafron Biomedical Co do? Jafron Biomedical Co Ltd is a China-based health care company headquartered in Zhuhai. The company focuses on the research, development, production, and sale of hemoperfusion products. It went public on August 2, 2016, with its stock listed under ticker 300529.SZ and ISIN CNE100002995. Jafron employs 3,003 full-time staff and operates within the health care sector. Its products include disposable hemoperfusion devices, hemoperfusion machines, disposable bilirubin adsorbers, the DX-10 blood purification machine, suture needles, and resin bandages. These products are used in treating conditions such as uremia, poisoning, severe liver diseases, autoimmune diseases, and multisystem organ failure. Jafron's products are distributed across more than 3,000 hospitals in all 31 provinces of China. The company's website is https://www.jafron.com/. Jafron Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jafron Biomedical Co stock

Intangible Assets of Jafron Biomedical Co is 97.75 M CNY in 2024.

Intangible Assets of Jafron Biomedical Co changed from 100.37 M CNY to 97.75 M CNY, representing a -2.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Jafron Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Jafron Biomedical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Jafron Biomedical Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Jafron Biomedical Co